Status:
COMPLETED
Meta-analysis of Efficacy of Topotecan
Lead Sponsor:
GlaxoSmithKline
Conditions:
Cervical Intraepithelial Neoplasia
Eligibility:
FEMALE
21+ years
Brief Summary
This meta-analysis was conducted to investigate the efficacy of Topotecan and other treatments for recurrent and stage IVB carcinoma of the cervix
Detailed Description
Studies included in the meta-analysis were: GOG-0179, GOG-0204 \& GOG-0169
Eligibility Criteria
Inclusion
- Randomised Clinical Trials or systematic reviews or meta-analyses
- Treatment with topotecan or platinum-based single and combination regimens in female patients of any race with cancer of the cervix recurrent after radiotherapy or stage IVB disease
Exclusion
- None
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01160185
Start Date
June 1 2009
End Date
July 1 2009
Last Update
July 12 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.